Krystal Biotech, Inc. KRYS Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Prepaid Expense and Other Assets at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s increase (decrease) in prepaid expense and other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s increase (decrease) in prepaid expense and other assets?
- Krystal Biotech, Inc. (KRYS) reported increase (decrease) in prepaid expense and other assets of $1.7M in Q1 2026.
- How has Krystal Biotech, Inc.'s increase (decrease) in prepaid expense and other assets changed year-over-year?
- Krystal Biotech, Inc.'s increase (decrease) in prepaid expense and other assets decreased by 50.5% year-over-year, from $3.43M to $1.7M.
- What is the long-term trend for Krystal Biotech, Inc.'s increase (decrease) in prepaid expense and other assets?
- Over 2 years (2021 to 2024), Krystal Biotech, Inc.'s increase (decrease) in prepaid expense and other assets has grown at a 236.3% compound annual growth rate (CAGR), from $691K to $7.82M.